enclosed space Genesys, Inc. (Foste...
enclosed space Genesys, Inc. (Foster City, CA) reported that a Phase 1/2 clinical trial of CG7870 an oncolytic virus engineered to target and pull down prostate cancer cells, demonstrated anticancer activity after no other than a single intravenous injection in enthralls with advanced hormone refractory prostate cancer. The trial, a dose meditation designed to evaluate the product's safety and efficacy, was
|